Abstract:The SARS-CoV-2 spike glycoprotein has 22 potential N-linked glycosylation sites per monomer that are highly conserved among diverse variants, but how individual glycans affect virus entry and neutralization of Omicron variants has not been extensively characterized. Here we compared the effects of specific glycan deletions or modifications in the Omicron BA.1 and D614G spikes on spike expression, processing, and incorporation into pseudoviruses, as well as on virus infectivity and neutralization by therapeutic antibodies. We found that loss of potential glycans at spike residues N717 and N801 each conferred a loss of pseudovirus infectivity for Omicron but not for D614G or Delta variants. This decrease in infectivity correlated with decreased spike processing and incorporation into Omicron pseudoviruses. Oligomannose-enriched Omicron pseudoviruses generated in GnTI- cells or in the presence of kifunensine were non-infectious, whereas D614G or Delta pseudoviruses generated under similar conditions remained infectious. Similarly, growth of live (authentic) SARS-CoV-2 in the presence of kifunensine resulted in a greater reduction of titers for the BA.1.1 variant than Delta or D614G variants relative to their respective, untreated controls. Finally, we found that loss of some N-glycans, including N343 and N234, increased the maximum percent neutralization by the class 3 S309 monoclonal antibody against D614G but not BA.1 variants, while these glycan deletions altered the neutralization potency of the class 1 COV2-2196 and Etesevimab monoclonal antibodies without affecting maximum percent neutralization. The maximum neutralization by some antibodies also varied with the glycan composition, with oligomannose-enriched pseudoviruses conferring the highest percent neutralization. These results highlight differences in the interactions between glycans and residues among SARS-CoV-2 variants that can affect spike expression, virus infectivity, and susceptibility of variants to antibody neutralization. The SARS-CoV-2 spike surface protein is covered in glycans that may affect its function and ability to evade antibodies. Omicron variants have over 30 mutations compared to the D614G variant, yet all 22 potential N-glycosylation sites are highly conserved. Here we compared the impact of glycan changes in the spikes of the Omicron and D614G variants on virus infectivity and neutralization. We found that loss of specific glycans in the transmembrane subunit of spike greatly reduced Omicron, but not D614G, spike expression and incorporation into pseudoviruses. Changes in the overall glycan composition also reduced the infectivity of Omicron compared to D614G in live virus and pseudovirus formats. We further show that changes in specific glycans directly or indirectly affected susceptibility of pseudoviruses to therapeutic antibodies, but the effects differed among the variants. These findings highlight differences in the interplay between glycans and spike amino acid residues among SARS-CoV-2 variants that can affect spike expression and function, as well as evasion of antibodies.

Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells

The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses

Correlation between Genomic Variants and Worldwide COVID-19 Epidemiology

The impact of immunoglobulin G N-glycosylation level on COVID-19 outcome: evidence from a Mendelian randomization study

Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern

Whole-genome sequencing reveals host factors underlying critical COVID-19

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort

The Crucial Role of Immune Factors in Susceptibility to SARS-CoV-2 Infection and Severity of COVID-19

Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects

Dissecting human population variation in single-cell responses to SARS-CoV-2

Trans-ethnic genome-wide association study of severe COVID-19

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Glycosylation in SARS-CoV-2 variants: A path to infection and recovery

Immunogenetic Predisposition to SARS-CoV-2 Infection

A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection

Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants